Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 68.0536.8019.3923.4127.87

What is the latest EV/Core EBITDA ratio of SUVEN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SUVEN PHARMACEUTICALS is 68.05 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202568.05
Mar202436.80
Mar202319.39
Mar202223.41
Mar202127.87

How is EV/Core EBITDA of SUVEN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 68.05
84.92
Mar2024 36.8
89.79
Mar2023 19.39
-17.17
Mar2022 23.41
-16.00
Mar2021 27.87 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹11,164.3 Cr -5.3% -23.4% -74.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,777.0 Cr -0.1% 4.7% 6.2% Stock Analytics
DIVIS LABORATORIES ₹168,931.0 Cr -1.7% 2.5% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,330.0 Cr -1.1% 7.6% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,593.0 Cr -0.4% 6.3% 14.7% Stock Analytics
CIPLA ₹107,112.0 Cr -2.3% 0.3% -8.9% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-5.3%

-23.4%

-74.3%

SENSEX

-2.8%

-2%

7.3%


You may also like the below Video Courses